June 5, 2019
German Federal Ministry of Education and Research Invests in New TB Treatments
TB Alliance receives a €10 million funding commitment for the development of faster and better tuberculosis treatments
May 22, 2019
Tuberculosis, Among the Oldest Infectious Diseases, Is Now the World’s Deadliest – It’s Time to Invest in Solutions
TB Alliance Statement from the 72nd World Health Assembly
May 21, 2019
New Research on Drug-Resistant TB Treatment Presented at ATS 2019
Presentations look at an analysis of nonclinical data regarding drug-resistant TB transmission and a clinical case study of a sterile TB granuloma of the brain
May 9, 2019
TB Alliance and Partners Form Multidisciplinary Center for Translational TB Drug Research
New collaboration, supported by U.S. National Institutes of Health, to produce two new clinical stage TB drug candidates
April 29, 2019
Joint Statement on Universal Health Coverage and TB Research
Moving Together to Build a Healthier World
April 25, 2019
A Conversation with Karl Hofmann
Looking back and looking forward with the outgoing president of TB Alliance's Stakeholders Association
April 18, 2019
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis
Regimens under clinical development include treatment options for drug-resistant forms of TB
March 20, 2019